During drug development, pharmaceutical companies primarily focus on "the average patient" with regard to deriving drug dosing regimens. Consequently, drug dosing in patient populations with altered drug disposition frequently remains off-label.
This research unit focusses on applied pharmacokinetic/pharmacodynamic (PK/PD) drug research in patient populations (e.g. children, critically ill, patients on hemodialysis, elderly, cancer patients). Ultimate goal is to develop evidence-based tailored dosing regimens. The research is performed in close collaboration with the hospital pharmacy and clinical departments of the Ghent University Hospital.

Research Projects

• Impact of Critical Illness on Drug Disposition in Neonates and Children
• Impact of Hemodialysis on Antibiotic Disposition in Adults
• Impact of Age and Frailty on Drug Disposition in Geriatric Adults.

Research Coordinator

Prof. dr. Peter De Paepe

List of Publications

Recente publicaties gelinkt aan de Ghent precision dosing unit

.

Team

• Supervisor: Prof. dr. Peter De Paepe , Prof. dr.. Pieter De Cock
• PhD students: Anh Thi Van Nguyen – Isis Van Herteryck – Arnaud De Clercq – Lotte Deschepper – Evelyn Dhont – Matthias De Langhe
• Researchers: Eline Hermans
• Clinical pharmacologists in training: Loes Van Mierop